JAMA Network
What The Study Did: Data for 1.3 million adults in France were used to compare the effectiveness of full vaccination of the Janssen vaccine with the Pfizer-BioNTech vaccine against COVID-19–related hospitalization.
Authors: Jérémie Botton, Pharm.D., Ph.D., of French National Health Insurance in Saint-Denis, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.0868)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
